Reduced prostaglandin F2αrelease from blood mononuclear leukocytes after oral supplementation of ω3 fatty acids: the OmegAD study

MLA

Vedin, Inger, et al. “Reduced Prostaglandin F2αrelease from Blood Mononuclear Leukocytes after Oral Supplementation of Ω3 Fatty Acids: The OmegAD Study.” Journal of Lipid Research, vol. 51, no. 5, May 2010, pp. 1179–85. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs21126566&authtype=sso&custid=ns315887.

APA

Vedin, I., Cederholm, T., Freund-Levi, Y., Basun, H., Hjorth, E., Irving, G. F., Eriksdotter-Jönhagen, M., Schultzberg, M., Wahlund, L.-O., & Palmblad, J. (2010). Reduced prostaglandin F2αrelease from blood mononuclear leukocytes after oral supplementation of ω3 fatty acids: the OmegAD study. Journal of Lipid Research, 51(5), 1179–1185.

Chicago

Vedin, Inger, Tommy Cederholm, Yvonne Freund-Levi, Hans Basun, Erik Hjorth, Gerd Faxén Irving, Maria Eriksdotter-Jönhagen, Marianne Schultzberg, Lars-Olof Wahlund, and Jan Palmblad. 2010. “Reduced Prostaglandin F2αrelease from Blood Mononuclear Leukocytes after Oral Supplementation of Ω3 Fatty Acids: The OmegAD Study.” Journal of Lipid Research 51 (5): 1179–85. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs21126566&authtype=sso&custid=ns315887.